Genetic Diagnostics Network
Attard/Antwerp - DNA tests are moving in a big way out of the research laboratory and into the realm of diagnostic medicine.
Fifty years after Watson and Crick published the structure of DNA in Nature, an extensive diagnostic genetic network has been launched under the name Gendia (GENetic DIAgnostics). The Network is supported by two companies: Synergene and AML. Synergene is a biotechnology company based in Malta, specialising in genetic testing. AML is a diagnostic medical laboratory based in Antwerp, offering a wide portfolio of medical diagnostic laboratory tests.
Gendia consists of a large group of closely collaborating laboratories throughout the world that refer patients' samples to the central Gendia clearing house in Belgium. The actual genetic tests are performed by 19 genetic laboratories.
In countries with already developed molecular diagnostics, the network will facilitate testing for rare diseases not covered by local labs. In countries with a less developed system for genetic diagnosis the network will provide access to many tests through the local referral labs. These labs can offer all the tests that the network is offering in their own country.